SpringWorks Therapeutics, Inc.
SWTX
$37.06
-$0.86-2.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 18.05% | 32.61% | 48.77% | -19.02% | -27.16% |
| Total Depreciation and Amortization | 89.03% | 77.73% | 120.94% | 188.14% | 110.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.71% | 15.84% | 17.01% | 27.76% | 37.65% |
| Change in Net Operating Assets | 404.27% | -130.07% | -676.75% | -77.52% | 2,315.57% |
| Cash from Operations | 52.95% | 49.71% | 12.59% | -27.68% | -15.69% |
| Capital Expenditure | -145.70% | 49.01% | 68.43% | 80.62% | 231.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 109.41% | -20.21% | -98.02% | -78.30% | 54.28% |
| Cash from Investing | 108.88% | -17.20% | -99.52% | -78.23% | 55.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.61% | 8,036.36% | 42,800.00% | 7,062.65% | 100,344.30% |
| Repurchase of Common Stock | -106.72% | -89.02% | -161.08% | -236.46% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.78% | 633.47% | 1,085.67% | 70.13% | 100,259.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -119.05% | 128.32% | -402.55% | -266.06% | 118.87% |